Stay updated on Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial
Sign up to get notified when there's something new on the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page.

Latest updates to the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page
- Check7 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe Italian site entry changes from Padua to Padova (35128).SummaryDifference0.0%

- Check36 days agoChange DetectedNaples, Italy, 80131 was added in place of Napoli, Italy, 80131. The page revision changed from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This is a minor site update and does not affect the study content.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page revision updates from v3.4.1 to v3.4.2 and does not affect study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision label on the page changed from v3.4.0 to v3.4.1. No visible changes to study content or functionality were observed.SummaryDifference0.1%

Stay in the know with updates to Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page.